During the past decade, Kyoto University Hospital conducted 92 clinical trials. In the 10-year time frame, 92 clinical trials started and 36 clinical trials were completed, i.e. on average, 39.1% percent of trials that started reached the finish line to date. In the past 5 years, 47 clinical trials started and 23 clinical trials were completed. i.e. 48.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kyoto University Hospital" #1 sponsor was "Hoffmann-La Roche" with 16 trials, followed by "Kyoto University" with 9 trials sponsored, "Pfizer" with 9 trials sponsored, "Takeda" with 8 trials sponsored and "Boehringer Ingelheim" with 8 trials sponsored. Other sponsors include 92 different institutions and companies that sponsored additional 65 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kyoto University Hospital" #1 collaborator was "Kyoto University" with 5 trials as a collaborator, "AstraZeneca" with 4 trials as a collaborator, "Ministry of Health, Labour and Welfare, Japan" with 4 trials as a collaborator, "Breast International Group" with 3 trials as a collaborator and "Eli Lilly and Company" with 3 trials as a collaborator. Other collaborators include 64 different institutions and companies that were collaborators in the rest 71 trials.

According to Clinical.Site data, the most researched conditions in "Kyoto University Hospital" are "Breast Cancer" (10 trials), "Coronary Artery Disease" (7 trials), "Gastric Cancer" (4 trials), "Ovarian Cancer" (4 trials) and "Biliary Tract Cancer" (3 trials). Many other conditions were trialed in "Kyoto University Hospital" in a lesser frequency.

Most popular intervention types in "Kyoto University Hospital" are "Drug" (116 trials), "Device" (16 trials), "Other" (13 trials), "Procedure" (13 trials) and "Biological" (9 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (22 trials), "Atezolizumab" (7 trials), "Cisplatin" (6 trials), "Gemcitabine" (6 trials) and "Paclitaxel" (6 trials). Other intervention names were less common.

The vast majority of trials in "Kyoto University Hospital" are 122 trials for "All" genders, 15 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Kyoto University Hospital". undefined are not yet recruiting, 26 are recruiting, 30 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 67 completed trials in Kyoto University Hospital, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Kyoto University Hospital, 12 "Phase 1" clinical trials were conducted, 36 "Phase 2" clinical trials and 77 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 13 trials that are defined as “Not Applicable".